Authors
Latest:
Vaccination Strategies Practice Pearls And Key Take AwaysDrs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.
Latest:
For Unknown Causes of Kidney Disease, Genetic Testing Holds PromiseA recent American Kidney Fund survey of 300 primary care and specialty clinicians found ~15% of their patients had kidney disease of unknown origin.
Latest:
Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two TrialsAcross two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.
Latest:
Take-home Messages for Acute Pain ManagementBenjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Latest:
Guidance for PCPs: Streamlining Menopause CarePanelists discuss strategies for simplifying complex information for primary care physicians (PCPs), provide tips on how PCPs can effectively communicate evidence-based treatment options to patients, and outline actionable points and key takeaways to enhance patient care in managing menopause symptoms.
Latest:
The CMS CED Policy Limits Treatment for Early Alzheimer's Disease: What It Is and How It WorksThe coverage with evidence development (CED) policy requires enrollment in an active clinical trial for an adult to be eligible for Medicare coverage of treatment for Alzheimer's disease.
Latest:
Cannabis: An "Ins and Outs" Primer for Primary CareA concise update on legal status, FDA approvals, patient safety, and public perception.
Latest:
Distinct Patterns of BP in Early Gestation Predict Hypertensive Disorders: StudyInvestigators identified 6 blood pressure patterns that, when combined with other risk factors, accurately stratified risk of hypertensive disorders of pregnancy.
Latest:
Final Pearls and Takeaways for Testing and Managing CKDExperts wrap up their discussion of emerging chronic kidney disease tests and treatments with key takeaways for providers and patients.
Latest:
FDA Ruling on National Breast Density Notification for Mammography Reports FinalizedBeginning on Sept 24, 2024, all women must be notified of their breast density status in mammography reports and encouraged to pursue supplemental screening.
Latest:
Two Biosimilars to Denosumab Win FDA Approval as Amgen and Sandoz Go to CourtBiosimilars Wyost and Jubobonti were approved as interchangeable for Xgeva and Prolia but launch will depend on the outcome of litigation between reference product manufacturers.
Latest:
First-Ever MDMA-Assisted Therapy for PTSD is Granted FDA Priority ReviewIf the FDA approves the treatment, it will be the first-ever MDMA-assisted therapy and psychedelic-assisted therapy. The PDUFA date is set for August 11, 2024.
Latest:
The Importance of Connecting Patients with ADPKD with Each OtherPeer mentor programs can provide support for patients, especially when it comes to family planning and parenthood.
Latest:
Michael A. Weber, MD, on aprocitentan approval: A new approach to managing hypertensionMichael A. Weber, MD, an investigator in the PRECISION study, discusses the newly FDA approved drug aprocitentan (Tryvio), and its promise for helping patients with treatment-resistant hypertension.
Latest:
Is Technology the Answer to Revitalized Primary Care?Health care leaders increasingly are looking to technology for solutions to the challenges facing primary care.
Latest:
Refining Diabetes Care for Older Adults: Expert Insights on Deprescribing, Streamlining Treatment, and Key Practice PearlsExperts on diabetes provide insights gleaned from the SIMPLE study and outline patient factors that inform treatment decisions.
Latest:
Coronary Artery Calcium Scoring: 7 Questions for Primary CareHow current are you on CAC and its place in CVD risk assessment? This short quiz will reveal your score.
Latest:
Efficacy of Latest COVID-19 VaccinesExperts discuss the efficacy of the latest vaccines against currently circulating strains of COVID-19, commenting on how long immunity lasts from these vaccines.
Latest:
The State of Vaccine Willingness in the US: A Primary Care and an Infectious Disease Physician DiscussWell-known ID specialist Bill Schaffner, MD, and active primary care educator Chuck Vega, MD, offer thoughts on how to get shots into arms in the 2023-2024 respiratory virus season.
Latest:
WHO Guideline Update Recommends Against 2 COVID-19 Monoclonal TreatmentsWHO: Evidence is lacking for clinical effectiveness of Xevudy and Regen-Cov against the COVID-19 variants that are currently circulating.
Latest:
Final Thoughts on Strategies for Managing and Monitoring Patients Receiving TeplizumabThe panel concludes its discussion with key takeaways on the optimal care of patients with type 1 diabetes care and thoughts on unmet needs within the treatment space.
Latest:
Screening Tools For OSAPanelists discuss how validated questionnaires, clinical assessment tools, and overnight monitoring devices can help identify patients at risk for obstructive sleep apnea, though polysomnography remains the gold standard for definitive diagnosis.
Latest:
Antiobesity Medication: An Effective Treatment Tool for the Right PatientObesity requires a spectrum of treatment options for effective results. Here, 3 key points to keep in mind when considering antiobesity medication for patients.
Latest:
Early Intervention in Weight Management: Treating Pre-ObesityResearch shows that increased risk of chronic disease and mortality begins below a BMI classified as obesity. The earlier we intervene with at-risk patients, the greater the chance for success.
Latest:
Take-Home Thoughts for Managing DiabetesEden Miller, DO, shares key takeaways on how personalized treatment helps in the management of diabetes.
Latest:
Cognitive Aging Research Program Reveals Insights Based on 25 Years of DataA 25-year study of the Lothian Birth Cohorts found that childhood intelligence, lifestyle factors, and brain health significantly impact cognitive aging and longevity.
Latest:
DEA Amends Telehealth Prescribing Rules, Including Special Registration for Schedule II-V MedicationsThe DEA action includes 3 new telehealth rules that make permanent several flexibilities enacted during the pandemic and also establish new protections for patients.
Latest:
Closing Thoughts on the Treatment of MDDRoger S. McIntyre, MD, FRCPC, and Carmen Kosicek, MSN, PMHNP-BC, discuss the future of MDD treatment and share closing thoughts.
